{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:50:24Z","timestamp":1777384224336,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gender Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.genm.2012.01.008","type":"journal-article","created":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T13:53:33Z","timestamp":1330178013000},"page":"76-93","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacologic Effects of 2-Methoxyestradiol on Angiotensin Type 1 Receptor Down-Regulation in Rat Liver Epithelial and Aortic Smooth Muscle Cells"],"prefix":"10.1016","volume":"9","author":[{"given":"Sivaramakrishna","family":"Koganti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Thekkumkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genm.2012.01.008_bib1","series-title":"Disorders of the Adrenal Cortex","author":"Williams","year":"2008"},{"key":"10.1016\/j.genm.2012.01.008_bib2","series-title":"Diabetes Mellitus","author":"Powers","year":"2008"},{"key":"10.1016\/j.genm.2012.01.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876526201003010001","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"3","author":"Wang","year":"2010","journal-title":"Open Hypertens J"},{"key":"10.1016\/j.genm.2012.01.008_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11906-007-0022-6","article-title":"The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function","volume":"9","author":"Tamura","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.genm.2012.01.008_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/hy1101.096109","article-title":"Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation","volume":"38","author":"Henrion","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.genm.2012.01.008_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/cvr\/cvn230","article-title":"Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction","volume":"81","author":"Ainscough","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.genm.2012.01.008_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11906-008-0050-x","article-title":"Evidence for benefits of angiotensin receptor blockade beyond blood pressure control","volume":"10","author":"Siragy","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.genm.2012.01.008_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/en.2008-0645","article-title":"17 beta-estradiol modulates expression of low-voltage-activated Ca(V)3.2 T-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes","volume":"150","author":"Marni","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.genm.2012.01.008_bib9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.genm.2012.01.008_bib10","doi-asserted-by":"crossref","first-page":"H1806","DOI":"10.1152\/ajpheart.00283.2009","article-title":"Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats","volume":"297","author":"Deschamps","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/aje\/kwk015","article-title":"Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review","volume":"165","author":"Olson","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.genm.2012.01.008_bib12","first-page":"2269","article-title":"Is 2-methoxy estradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?","volume":"58","author":"Zhu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.genm.2012.01.008_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1530\/acta.0.1000154","article-title":"Concentrations of 2-hydroxyoestrogens in human sera measured by a heterologous immunoassay with an 125I-labelled ligand","volume":"100","author":"Berg","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.genm.2012.01.008_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.physiol.70.113006.100518","article-title":"Estrogen signaling through the transmembrane G protein\u2013coupled receptor GPR30","volume":"70","author":"Prossnitz","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes","volume":"19","author":"Bjornstrom","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.genm.2012.01.008_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0039-128X(99)00107-5","article-title":"Estrogen receptor interaction with co-activators and co-repressors","volume":"65","author":"Klinge","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.genm.2012.01.008_bib17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/me.13.10.1672","article-title":"The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions","volume":"13","author":"Webb","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.genm.2012.01.008_bib18","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1074\/jbc.M101806200","article-title":"Characterization of the physical interaction between estrogen receptor and JUN proteins","volume":"276","author":"Teyssier","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","article-title":"Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase","volume":"270","author":"Kato","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.genm.2012.01.008_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1097-2765(00)80479-7","article-title":"Ligand-independent recruitment of SRC-1 to estrogen receptor through phosphorylation of activation function AF-1","volume":"3","author":"Tremblay","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.genm.2012.01.008_bib21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI200317261","article-title":"Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids","volume":"111","author":"Kousteni","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.genm.2012.01.008_bib22","doi-asserted-by":"crossref","first-page":"43363","DOI":"10.1074\/jbc.M304363200","article-title":"Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line","volume":"278","author":"Kawagoe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.genm.2012.01.008_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J"},{"key":"10.1016\/j.genm.2012.01.008_bib25","first-page":"286","article-title":"MAPK cascades in cell growth and death","volume":"12","author":"Neary","year":"1997","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.genm.2012.01.008_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2001-14937","article-title":"Effects of androgens and estrogens and catechol and methoxy-estrogen derivatives on mitogen activated protein kinase (ERK 1,2) activity in SW-13 in human adrenal carcinoma cells","volume":"33","author":"Brown","year":"2001","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.genm.2012.01.008_bib27","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1523\/JNEUROSCI.19-11-04211.1999","article-title":"Mitogenic signaling by ATP P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C calcium pathway","volume":"19","author":"Neary","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.genm.2012.01.008_bib28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genm.2012.01.008_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2012.01.008_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/157016111794519327","article-title":"Effects of estrogens on atherogenesis","volume":"9","author":"Kolovou","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.genm.2012.01.008_bib31","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2002-02-0376","article-title":"2-Methoxyestradiol overcomes drug resistance in multiple myeloma","volume":"100","author":"Chauhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.genm.2012.01.008_bib32","first-page":"3948","article-title":"Promising preclinical activity of 2-methoxyestradiol in multiple myeloma","volume":"8","author":"Dingli","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.genm.2012.01.008_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2011.03.006","article-title":"Role of 2-methoxyestradiol as inhibitor of arthritis and osteoporosis in a model of postmenopausal rheumatoid arthritis","volume":"140","author":"Stubelius","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.genm.2012.01.008_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000135627","article-title":"Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis","volume":"15","author":"Garay","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.genm.2012.01.008_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1386.021","article-title":"A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"1089","author":"Offner","year":"2006","journal-title":"Ann NY Acad Sci"},{"issue":"2 Pt 2","key":"10.1016\/j.genm.2012.01.008_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/01.HYP.37.2.640","article-title":"Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism","volume":"37","author":"Dubey","year":"2001","journal-title":"Hypertension"},{"issue":"1 Pt 2","key":"10.1016\/j.genm.2012.01.008_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.HYP.31.1.522","article-title":"17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth","volume":"31","author":"Dubey","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.genm.2012.01.008_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/01.ATV.20.4.964","article-title":"Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity","volume":"20","author":"Dubey","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.genm.2012.01.008_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/bbrc.2000.3755","article-title":"Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms","volume":"278","author":"Dubey","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.genm.2012.01.008_bib40","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/HYPERTENSIONAHA.110.152298","article-title":"Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection","volume":"56","author":"Barchiesi","year":"2010","journal-title":"Hypertension"},{"issue":"5 Pt 2","key":"10.1016\/j.genm.2012.01.008_bib41","first-page":"F897","article-title":"Angiotensin (AT1A) receptor-mediated increases in transcellular sodium transport in proximal tubule cells","volume":"274","author":"Thekkumkara","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0165-6147(92)90139-W","article-title":"How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown","volume":"13","author":"Swillens","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.genm.2012.01.008_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"Pt 2","key":"10.1016\/j.genm.2012.01.008_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/bj20020960","article-title":"Evidence for involvement of 3\u2032-untranslated region in determining angiotensin II receptor coupling specificity to G-protein","volume":"370","author":"Thekkumkara","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.genm.2012.01.008_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","article-title":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor","volume":"351","author":"Murphy","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.genm.2012.01.008_bib46","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib47","doi-asserted-by":"crossref","DOI":"10.1530\/JME-11-0095","article-title":"13-Cis retinoic acid specific down-regulation of angiotensin type 1 receptor in rat liver epithelial and aortic smooth muscle cells","author":"Snyder","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.genm.2012.01.008_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0014-4827(84)90666-9","article-title":"A diploid epithelial cell line from normal adult rat liver with phenotypic properties of \u201coval\u201d cells","volume":"154","author":"Tsao","year":"1984","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.genm.2012.01.008_bib49","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1093\/emboj\/17.9.2574","article-title":"Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G\u2013protein coupled receptor\u2013EGF receptor transactivation pathway","volume":"17","author":"Li","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.genm.2012.01.008_bib50","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.270.47.28440","article-title":"Angiotensin II activates at least two tyrosine kinases in rat liver epithelial cells: separation of the major calcium-regulated tyrosine kinase from p125FAK","volume":"270","author":"Earp","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib51","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1073\/pnas.89.18.8837","article-title":"Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II","volume":"89","author":"Huckle","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.genm.2012.01.008_bib52","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1128\/MCB.10.12.6290","article-title":"Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner","volume":"10","author":"Huckle","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.genm.2012.01.008_bib53","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.272.22.14341","article-title":"Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells","volume":"272","author":"Li","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib54","doi-asserted-by":"crossref","first-page":"14996","DOI":"10.1074\/jbc.272.23.14996","article-title":"Protein kinase C and protein kinase A inhibit calcium-dependent but not stress-dependent c-Jun N-terminal kinase activation in rat liver epithelial cells","volume":"272","author":"Li","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)84858-5","article-title":"The epidermal growth factor receptor tyrosine kinase in liver epithelial cells: the effect of ligand-dependent changes in cellular location","volume":"264","author":"McCune","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.genm.2012.01.008_bib56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.1041260204","article-title":"The effects of epidermal growth factor and the state of confluence on enzymatic activities of cultured rat liver epithelial cells","volume":"126","author":"Tsao","year":"1986","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib57","doi-asserted-by":"crossref","first-page":"12454","DOI":"10.1074\/jbc.272.19.12454","article-title":"Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells: evidence for involvement of the proteasome pathway","volume":"272","author":"Bokkala","year":"1997","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"10.1016\/j.genm.2012.01.008_bib58","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1042\/0264-6021:3570769","article-title":"Effect of angiotensin II and ethanol on the expression of connexin 43 in WB rat liver epithelial cells","volume":"357","author":"Bokkala","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.genm.2012.01.008_bib59","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1523-1755.2002.00204.x","article-title":"High glucose down-regulates angiotensin II binding via the PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells","volume":"61","author":"Park","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.genm.2012.01.008_bib60","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/jpet.109.161075","article-title":"Prehypertensive preconditioning improves adult antihypertensive and cardioprotective treatment","volume":"332","author":"Baumann","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.genm.2012.01.008_bib61","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.1523\/JNEUROSCI.22-19-08391.2002","article-title":"ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury","volume":"22","author":"Toran-Allerand","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.genm.2012.01.008_bib62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cld.2009.07.001","article-title":"Pharmacologic therapy of non-alcoholic steatohepatitis","volume":"13","author":"Ratziu","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.genm.2012.01.008_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00280-010-1478-7","article-title":"A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors","volume":"68","author":"Kulke","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.genm.2012.01.008_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4161\/cbt.5.1.2349","article-title":"Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors","volume":"5","author":"Dahut","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.genm.2012.01.008_bib65","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.RES.0000236802.00855.cd","article-title":"Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis?","volume":"99","author":"Dantas","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.genm.2012.01.008_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0960-0760(01)00090-5","article-title":"2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics","volume":"78","author":"Brueggemeier","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.genm.2012.01.008_bib67","doi-asserted-by":"crossref","first-page":"H1935","DOI":"10.1152\/ajpheart.00723.2008","article-title":"Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol","volume":"295","author":"Gui","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib68","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","article-title":"Gender, sex hormones, and vascular tone","volume":"286","author":"Orshal","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4 Pt 2","key":"10.1016\/j.genm.2012.01.008_bib69","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.HYP.34.4.931","article-title":"Gender differences in Ca(2+) entry mechanisms of vasoconstriction in Wistar-Kyoto and spontaneously hypertensive rats","volume":"34","author":"Crews","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.genm.2012.01.008_bib70","doi-asserted-by":"crossref","first-page":"C34","DOI":"10.1152\/ajpcell.2001.280.1.C34","article-title":"Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle","volume":"280","author":"Kanashiro","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib71","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.38.3.718","article-title":"Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction","volume":"38","author":"Granger","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.genm.2012.01.008_bib72","doi-asserted-by":"crossref","first-page":"SIV22","DOI":"10.1016\/S0140-6736(98)90284-7","article-title":"Preterm birth and pre-eclampsia: bad news and good news","volume":"352","author":"Roberts","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.genm.2012.01.008_bib73","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-0528.1981.tb02222.x","article-title":"Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation","volume":"88","author":"Gerretsen","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.genm.2012.01.008_bib74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbaexp.2004.09.008","article-title":"Transcriptional regulation of the AT1 receptor gene in immortalized human trophoblast cells","volume":"1680","author":"Duffy","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.genm.2012.01.008_bib75","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.placenta.2006.10.008","article-title":"Murine pre-eclampsia induced by unspecific activation of the immune system correlates with alterations in the eNOS and AT1 receptor expression in the kidneys and placenta","volume":"28","author":"Schmid","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.genm.2012.01.008_bib76","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1113\/jphysiol.2002.034116","article-title":"Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries","volume":"548","author":"Itoh","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.genm.2012.01.008_bib77","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature06951","article-title":"Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia","volume":"453","author":"Kanasaki","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.genm.2012.01.008_bib78","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.103.058057","article-title":"Cardiovascular pharmacology of estradiol metabolites","volume":"308","author":"Dubey","year":"2004","journal-title":"JPET"},{"key":"10.1016\/j.genm.2012.01.008_bib79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mce.2006.12.010","article-title":"GPR30: a G protein-coupled receptor for estrogen","volume":"265\u2013266","author":"Prossnitz","year":"2007","journal-title":"MolCell Endocrinol"},{"key":"10.1016\/j.genm.2012.01.008_bib80","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/me.14.10.1649","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.genm.2012.01.008_bib81","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.genm.2012.01.008_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/me.16.1.70","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.genm.2012.01.008_bib83","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2004-1064","article-title":"Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells","volume":"146","author":"Thomas","year":"2005","journal-title":"Endocrinology"},{"issue":"1 Pt 2","key":"10.1016\/j.genm.2012.01.008_bib84","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.HYP.35.1.262","article-title":"Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway","volume":"35","author":"Dubey","year":"2000","journal-title":"Hypertension"}],"container-title":["Gender Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550857912000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550857912000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:13:44Z","timestamp":1640909624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550857912000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1550857912000484"],"URL":"https:\/\/doi.org\/10.1016\/j.genm.2012.01.008","relation":{},"ISSN":["1550-8579"],"issn-type":[{"value":"1550-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}